WHO ICTRP trial
Remifentanil infusion effect on oocyte retrieval
IRCT201611177013N15 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201611177013N15 |
|---|---|
| Public title | Remifentanil infusion effect on oocyte retrieval |
| Scientific title | Comparison of anesthesia by Remifentanil with or without Propofol for Transvaginal Ultrasonography Oocyte Retrieval (TUGOR) on pregnancy and anesthesia outcomes in patients candidate for in vitro fertilization |
| Primary sponsor | Vice chancellor for research, Tabriz University of medical sceinces |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Anethestics complication and efficacy. Complications of anaesthesia during pregnancy;Complications of anaesthesia during pregnancy |
| Interventions | Intervention 1: Intervention group: 0.25 µg/kg/min remifentanil will be infused during operation. Intervention 2: Control group: 1 µg/kg/min remifentanil combined with 50-150 µg/kg/min propofol will be infused during operation.;Treatment… |
| Registration date | Dec 24, 2016 |
| Target size | 180 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: